Introduction {#sec1_1}
============

*Clostridium difficile*-associated diarrhoea (CDAD) represents the leading cause of nosocomial diarrhoea in Europe and North America \[[@B1], [@B2]\]. It occurs most frequently in the elderly, immunocompromised or long-term care residents, and in association with broad-spectrum antibiotic use. However, there are increasingly numerous reports of community-acquired CDAD \[[@B2], [@B3]\], occurring in individuals who have had no contact with a healthcare facility in the preceding 12 weeks \[[@B2]\]. It has almost certainly been underreported and is increasingly recognised as an emerging problem. A recent United Kingdom-based study demonstrated a 2.1% prevalence of toxin positivity in community-acquired diarrhoeal samples \[[@B4]\]. The toxins of *C. difficile* have also been found in 3-5% of faecal specimens from asymptomatic members of the population, making it difficult to ascertain the true prevalence of community-acquired CDAD \[[@B2], [@B4], [@B5]\]. Acute renal failure (ARF) is common in the hospital setting, particularly in the elderly and in response to hypovolaemia, but is only rarely described as a direct result of CDAD \[[@B3]\].

McKittrick-Wheelock syndrome was originally described in 1954 \[[@B6]\] and has been reported in the literature on fewer than 50 occasions since. The syndrome encompasses a triad of (i) profound volume and electrolyte depletion secondary to (ii) hypersecretory mucous diarrhoea arising from (iii) a giant villous adenoma of the rectum or sigmoid colon.

In this report we describe the clinical presentations and outcome of a patient who suffered two separate episodes of ARF, with complete functional recovery in the interim, arising from these two rare and independent colonic pathologies. A brief review of CDAD and McKittrick-Wheelock syndrome is also presented.

Case Report {#sec1_2}
===========

In July 2007, a 65-year-old obese Caucasian British woman, with a family history of colorectal carcinoma (mother and grandmother), was admitted acutely to hospital. She reported 2 weeks of general malaise and had stopped all oral intake over the prior 48 h. She described 24 h of vomiting, syncopal episodes and double incontinence of profuse brown liquid faeces and offensive urine.

She presented confused and disoriented with extensive bruises covering her arms and torso. She was hypothermic and severely shocked. Her blood results indicated sepsis, hypokalaemic metabolic acidosis, salt and water depletion and ARF ([**table**]{.ul} [[**1**]{.ul}](#T1){ref-type="table"}). She was resuscitated with intravenous fluids, administered intravenous gentamicin and meropenem and immediately taken to the intensive therapy unit where she remained on inotropic support (dobutamine) and haemofiltration for 3 days. Renal ultrasound and an autoimmune screen were reported as normal. Urinalysis revealed only hyaline casts. A blood film demonstrated leukopaenia, large platelets without fragmentation and toxic granulation of neutrophils, consistent with an infective aetiology. There was no evidence of haemolysis or a microangiopathic process. Skin biopsies of the bruises were consistent with uraemic platelet dysfunction.

After 48 h on the intensive therapy unit, a sample of the patient\'s diarrhoea taken on initial arrival at hospital confirmed the presence of *C. difficile* toxin (Premier^TM^ Toxins A and B ELISA, Meridian Bioscience Inc.). After confirming with the patient\'s general practitioner that there had been no recent exposure to antibiotics, she was diagnosed with community-acquired *C. difficile* infection. Treatment was changed to intravenous metronidazole and oral vancomycin and the other antibiotics were discontinued. After 1 week she was transferred to a medical ward. All antibiotics were discontinued by day 15, after her diarrhoea had stopped. She returned home 2 days later with a normal creatinine of 89 μmol/l and a urea of 5.8 mmol/l.

In November 2008, the patient returned with a shorter 48-hour history of vomiting, anuria and falls. Initial assessment found her in better condition than when she had originally presented in July 2007. She was in ARF, however without evidence of circulatory shock, sepsis or acidaemia (table [1](#T1){ref-type="table"}). On this occasion she revealed that she had been producing frequent, clear mucus stools for an indeterminate number of weeks. Again, there was no preceding history of antibiotic use, but stool samples were negative for *C. difficile* toxin. Digital rectal examination by a junior doctor revealed an unusual spongy feel to the wall of the rectum. This was therefore followed by flexible sigmoidoscopy and magnetic resonance imaging to discover an extensive, circumferential soft fleshy lesion, carpeting 90% of the rectum from 2 cm above the anal verge to a depth of 12 cm ([**fig.**]{.ul} [[**1**]{.ul}](#F1){ref-type="fig"}). Biopsy confirmed a non-malignant, highly secretory villous adenoma.

Initial management with intravenous fluid and electrolyte replacement returned her renal function to baseline levels within 48 h. Definitive treatment, however, required surgical resection of the lesion. Following pre-operative counseling the patient elected non-restorative surgery and underwent laparoscopically-assisted abdomino-perineal excision of the rectum, as the extent of the tumour made it unamenable to local resection. The patient unfortunately suffered postoperative adhesional bowel obstruction (a small bowel loop adherent within the pelvis) necessitating re-intervention 4 weeks later in the form of an ileocaecal resection and double-barrelled ileostomy-colonic mucus fistula formation. She underwent successful stoma reversal 6 months later and remains well.

Discussion {#sec1_3}
==========

Approximately 8 litres of secretions and additional fluids pass through the gastrointestinal tract per day, with less than 100 ml eventually entering the faeces. The majority of resorption occurs in the colon. Alterations to colonic epithelial permeability, transit time, or intestinal content may destabilise this balance towards net loss. Severe or prolonged diarrhoeal illnesses can cause excessive depletion of salt and water from the gastrointestinal tract, leading to hypovolaemia, renal hypoperfusion and acute renal injury. The biochemical picture is usually one of hyperchloraemic metabolic acidosis with a normal anion gap, as there is a primary loss of bicarbonate from the gastrointestinal tract, with a compensatory hyperchloraemia \[[@B7]\]. In contrast, villous adenomas produce a secretory mucous diarrhoea that contains large amounts of potassium, sodium and chloride so that the classical clinical picture is one of hypokalaemic, hypochloraemic metabolic acidosis with a high anion gap \[[@B8], [@B9]\].

Our patient presented on both occasions with ARF, hyponatraemia and profound hypovolaemia requiring urgent fluid and electrolyte resuscitation, which is fundamental to successful treatment. Unfortunately the serum chloride and anion gap were not measured during either admission, which might have been helpful in formulating a differential diagnosis \[[@B7]\].

Although her rectal adenoma may well have been present and contributing to the intestinal discharge at her first presentation, given the clinical, serological and microbiological findings at the time, on balance of probabilities this was most likely a near-fatal manifestation of severe community-acquired CDAD. Community-acquired CDAD is more likely to occur in elderly patients with certain co-morbidities and risk factors ([**table**]{.ul} [[**2**]{.ul}](#T2){ref-type="table"}) \[[@B10]\].

Clinical infection with *C. difficile* is almost always associated with initial disruption of the colonic microflora by broad-spectrum antibiotics \[[@B3], [@B4], [@B11]\]. Then follows the expression of at least two major toxins -- toxins 'A' and 'B' \[[@B2], [@B11]\]. The latter irreversibly glycosylates members of the Ras family of small GTPases, causing degradation of the actin cytoskeleton and disruption of epithelial tight junctions \[[@B11]\]. The colonic epithelium becomes inflamed and begins to lose salt and water, resulting in a profuse diarrhoea. It follows that a prolonged episode of diarrhoea would eventually result in systemic losses of salt and water, and thus hypovolaemic renal failure. Interestingly however, there are only 4 reports of this in the literature \[[@B3]\].

Despite its 'B' toxin modifying small GTPases involved in transcriptional regulation, cellular proliferation and apoptosis \[[@B11]\], there are no reports of *C. difficile* infection promoting adenomatous transformation of the colonic epithelium such as would link our patient\'s two pathologies. Her second presentation was consistent with the syndrome originally described by McKittrick and Wheelock \[[@B6]\] as evidenced by the extensive hypersecretory rectal adenoma.

To effect significant volume loss, the adenoma underlying McKittrick-Wheelock syndrome must measure some 7-18 cm in greatest dimension and cover a large percentage of the mucosal surface of the rectum or sigmoid colon \[[@B12]\], as more proximal adenomas may still allow for sufficient reabsorption of effluent \[[@B12], [@B13]\]. The rarity of the syndrome is therefore explained by autopsy studies which have demonstrated that only 13-16% of villous adenomas reach \>2 cm in diameter \[[@B9]\], of which only 3% are secretory \[[@B14]\]. With regards to clinical management, the high rate of malignant transformation in large villous adenomas \[[@B9], [@B13]\], and mortality attached to untreated McKittrick-Wheelock syndrome \[[@B9], [@B13]\], suggests that pharmacological control of volume loss by the potent COX inhibitor indomethacin should only be considered as a temporising measure until the patient is stabilised for definitive surgical resection \[[@B9], [@B12], [@B14]\]. Our patient has done well following rectal excision, without any lasting evidence of renal impairment or further episodes of ARF.

In summary, we have described two episodes of ARF resulting from two uncommon and independent colorectal pathologies in order to highlight their importance when considering the differentials of ARF in diarrhoeal disease.
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![Sagittal mid-rectal MR image demonstrating the extent of the superficial villous adenoma which led to McKittrick-Wheelock syndrome in our patient. It covers nearly the entirety of the patient\'s rectum from 2 cm above the anal verge to a depth of 12 cm.](crg0005-0438-f01){#F1}

###### 

Blood results and vital signs

  Parameter               Reference range for women   July 2007   November 2008
  ----------------------- --------------------------- ----------- ---------------
  Hb, g/dl                11.5--15.2                  **18.0**    14.4
  WCC, × 10^9^/l          3.9--11                     **22.8**    10.4
  Platelets, × 10^9^/l    147--397                    **451**     **445**
  Haematocrit, %          36--46                      **51.2**    41.0
  pH                      7.340--7.450                **7.300**   7.492
  HC0~3~, mmol/l          18--23                      **11.2**    23.3
  Base excess, mEq/1      −2.0 to+2.0                 **-15.2**   \+ 1.0
  Lactate, mmol/l         0.5--1.6                    **4.32**    --
  Na^+^, mmol/l           135--145                    **116**     **122**
  K^+^, mmol/l            3.5--5.3                    4.9         **2.5**
  Urea, mmol/l            2.5--6.6                    **100**     **78**
  Creatinine, μmol/l      60--125                     **966**     **611**
  Chloride, mmol/l        95--105                     --          --
  Glucose, mmol/l         3.0--5.4                    10.2        --
  Temperature, °C                                     **35.4**    37.0
  Heart rate                                          **130**     71
  Blood pressure, mm Hg                               **70/35**   105/70
  SO~2~ (on air), %                                   **75**      95

Abnormal results in bold.

###### 

Risk factors for community-acquired *C. difficile* infection (after Dial et al. 2006 \[[@B10]\])

  Gastrointestinal       Adjusted OR (95% CI)   Medications              Adjusted OR (95% CI)   Others                          Adjusted OR (95% CI)
  ---------------------- ---------------------- ------------------------ ---------------------- ------------------------------- ----------------------
  IBD                    46.1 (14.5--146.7)     Antibiotics              8.2 (6.1--11.0)        Leukaemia/lymphoma              10.3 (1.3--81.5)
  Pernicious anaemia     6.0 (0.2--149.9)       Proton pump inhibitors   3.5 (2.3--5.2)         MRSA                            8.9 (1.7--46.6)
  Peptic ulcer disease   2.9 (0.4--1.9)                                                         Renal failure (inc. dialysis)   6.2 (2.7--13.9)
  Diverticular disease   1.5 (0.5--4.4)                                                         Solid tumours                   4.9 (1.5--16.5)

IBD = Inflammatory bowel disease.
